Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Skye Bioscience, Inc. Common Stock

SKYE
Current price
5.51 USD +0.13 USD (+2.42%)
Last closed 5.31 USD
ISIN US83086J1016
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 173 231 696 USD
Yield for 12 month +282.64 %
1Y
3Y
5Y
10Y
15Y
SKYE
21.11.2021 - 28.11.2021

Skye Bioscience, Inc., a biopharmaceutical company, focuses on unlocking new therapeutic pathways for metabolic health through the development of molecules that modulate G-protein coupled receptors. The company is conducting a Phase 2 clinical trial in obesity for nimacimab, a negative allosteric modulating antibody that peripherally inhibits CB1. This study is also assessing the combination of nimacimab and a GLP-1R agonist (Wegovy). The company was formerly known as Emerald Bioscience, Inc. and changed its name to Skye Bioscience, Inc. in January 2021. The company is headquartered in San Diego, California. Address: 11250 El Camino Real, San Diego, CA, United States, 92130

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

18 USD

P/E ratio

Dividend Yield

Current Year

Last Year

Current Quarter

Last Quarter

Current Year

-124 251 USD

Last Year

-114 998 USD

Current Quarter

Last Quarter

Key Figures SKYE

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -23 463 360 USD
Operating Margin TTM
PE Ratio
Return On Assets TTM -30.39 %
PEG Ratio
Return On Equity TTM -54.82 %
Wall Street Target Price 18 USD
Revenue TTM
Book Value 2.5 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings per share -3.6 USD
Diluted Eps TTM -3.6 USD
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics SKYE

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History SKYE

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:250
Payout Ratio
Last Split Date 08.09.2023
Dividend Date

Stock Valuation SKYE

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue
Price Sales TTM
Enterprise Value EBITDA -2.5612
Price Book MRQ 2.3793

Financials SKYE

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators SKYE

For 52 weeks

1.44 USD 19.41 USD
50 Day MA 4.87 USD
Shares Short Prior Month 1 214 388
200 Day MA 8.34 USD
Short Ratio 2.43
Shares Short 1 417 276
Short Percent 6.99 %